145 related articles for article (PubMed ID: 23328379)
21. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036
[TBL] [Abstract][Full Text] [Related]
22. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
[TBL] [Abstract][Full Text] [Related]
23. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
Lin JJ; Wu W; Jiang XF; Jin XJ; Lu LJ; Bao LW
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):144-7. PubMed ID: 23714672
[TBL] [Abstract][Full Text] [Related]
24. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
25. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
[TBL] [Abstract][Full Text] [Related]
26. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
Yang P; Liang M; Zhang Y; Shen B
Adv Ther; 2008 Aug; 25(8):787-94. PubMed ID: 18670743
[TBL] [Abstract][Full Text] [Related]
27. Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Milan criteria.
Liu PH; Lee YH; Hsu CY; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg Oncol; 2014 Nov; 21(12):3835-43. PubMed ID: 24903236
[TBL] [Abstract][Full Text] [Related]
28. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
[TBL] [Abstract][Full Text] [Related]
29. [Comparision of different interventional therapies for primary liver cancer].
Liu YM; Qin H; Wang CB; Fang XH; Ma QY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
[TBL] [Abstract][Full Text] [Related]
31. [Effect of CIK on long-term survival in the treatment of HCC after RFA combined TACE].
Pan GZ; Xu JB; Hao L; Zhang J; Li SL; Yuan QZ
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(9):689-92. PubMed ID: 27055505
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
Yi PS; Huang M; Zhang M; Xu L; Xu MQ
Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
Peng ZW; Chen MS
Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence.
Yan Q; Ni J; Zhang GL; Yao X; Yuan WB; Zhou L; Zheng SS
Chin Med J (Engl); 2013 Mar; 126(5):855-9. PubMed ID: 23489790
[TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
37. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
[TBL] [Abstract][Full Text] [Related]
38. Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting.
Yang HJ; Lee JH; Lee DH; Yu SJ; Kim YJ; Yoon JH; Kim HC; Lee JM; Chung JW; Yi NJ; Lee KW; Suh KS; Lee HS
Radiology; 2014 Jun; 271(3):909-18. PubMed ID: 24520944
[TBL] [Abstract][Full Text] [Related]
39. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
[TBL] [Abstract][Full Text] [Related]
40. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
